235 related articles for article (PubMed ID: 32219704)
1. PFKP is highly expressed in lung cancer and regulates glucose metabolism.
Shen J; Jin Z; Lv H; Jin K; Jonas K; Zhu C; Chen B
Cell Oncol (Dordr); 2020 Aug; 43(4):617-629. PubMed ID: 32219704
[TBL] [Abstract][Full Text] [Related]
2. Platelet isoform of phosphofructokinase promotes aerobic glycolysis and the progression of non‑small cell lung cancer.
Wang F; Li L; Zhang Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236133
[TBL] [Abstract][Full Text] [Related]
3. Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression.
Fan Y; Wang J; Xu Y; Wang Y; Song T; Liang X; Jin F; Su D
Cell Commun Signal; 2021 Feb; 19(1):18. PubMed ID: 33588886
[TBL] [Abstract][Full Text] [Related]
4. PFKP phenotype in lung cancer: prognostic potential and beyond.
Ganapathy-Kanniappan S
Mol Biol Rep; 2020 Oct; 47(10):8271-8272. PubMed ID: 32915402
[TBL] [Abstract][Full Text] [Related]
5. Glycolysis regulator PFKP induces human melanoma cell proliferation and tumor growth.
Chen C; Zhang X
Clin Transl Oncol; 2023 Jul; 25(7):2183-2191. PubMed ID: 36792847
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
Umar SM; Kashyap A; Kahol S; Mathur SR; Gogia A; Deo SVS; Prasad CP
Exp Cell Res; 2020 Nov; 396(1):112282. PubMed ID: 32919954
[TBL] [Abstract][Full Text] [Related]
7. PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism.
Lang L; Chemmalakuzhy R; Shay C; Teng Y
Adv Exp Med Biol; 2019; 1134():243-258. PubMed ID: 30919341
[TBL] [Abstract][Full Text] [Related]
8. Silencing PFKP restrains the stemness of hepatocellular carcinoma cells.
Sha X; Wang K; Wang F; Zhang C; Yang L; Zhu X
Exp Cell Res; 2021 Oct; 407(1):112789. PubMed ID: 34418458
[TBL] [Abstract][Full Text] [Related]
9. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress.
Kim NH; Cha YH; Lee J; Lee SH; Yang JH; Yun JS; Cho ES; Zhang X; Nam M; Kim N; Yuk YS; Cha SY; Lee Y; Ryu JK; Park S; Cheong JH; Kang SW; Kim SY; Hwang GS; Yook JI; Kim HS
Nat Commun; 2017 Feb; 8():14374. PubMed ID: 28176759
[TBL] [Abstract][Full Text] [Related]
10. PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer.
Yeerken D; Hong R; Wang Y; Gong Y; Liu R; Yang D; Li J; Fan J; Chen J; Zhang W; Zhan Q
PLoS One; 2020; 15(5):e0233750. PubMed ID: 32470015
[TBL] [Abstract][Full Text] [Related]
11. Platelet isoform of phosphofructokinase accelerates malignant features in breast cancer.
Inaishi T; Shibata M; Ichikawa T; Kanda M; Hayashi M; Soeda I; Takeuchi D; Takano Y; Tsunoda N; Kodera Y; Kikumori T
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34751415
[TBL] [Abstract][Full Text] [Related]
12. Phosphofructokinase Platelet Overexpression Accelerated Colorectal Cancer Cell Growth and Motility.
Lu TJ; Yang YF; Cheng CF; Tu YT; Chen YR; Lee MC; Tsai KW
J Cancer; 2023; 14(6):943-951. PubMed ID: 37151384
[No Abstract] [Full Text] [Related]
13. Krüppel-like factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer.
Moon JS; Kim HE; Koh E; Park SH; Jin WJ; Park BW; Park SW; Kim KS
J Biol Chem; 2011 Jul; 286(27):23808-16. PubMed ID: 21586797
[TBL] [Abstract][Full Text] [Related]
14. VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.
Zhou K; Yao YL; He ZC; Chen C; Zhang XN; Yang KD; Liu YQ; Liu Q; Fu WJ; Chen YP; Niu Q; Ma QH; Zhou R; Yao XH; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
Cell Death Dis; 2018 Sep; 9(10):988. PubMed ID: 30250190
[TBL] [Abstract][Full Text] [Related]
15. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
Chen L; Hu N; Wang C; Zhao H
Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis.
Lee JH; Liu R; Li J; Zhang C; Wang Y; Cai Q; Qian X; Xia Y; Zheng Y; Piao Y; Chen Q; de Groot JF; Jiang T; Lu Z
Nat Commun; 2017 Oct; 8(1):949. PubMed ID: 29038421
[TBL] [Abstract][Full Text] [Related]
17. p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP.
Huang Y; Xiong C; Wang C; Deng J; Zuo Z; Wu H; Xiong J; Wu X; Lu H; Hao Q; Zhou X
Cell Rep; 2023 Nov; 42(11):113426. PubMed ID: 37967006
[TBL] [Abstract][Full Text] [Related]
18. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.
Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X
Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827
[TBL] [Abstract][Full Text] [Related]
19. Triptolide impairs glycolysis by suppressing GATA4/Sp1/PFKP signaling axis in mouse Sertoli cells.
Zhang Y; Tang Y; Luo Y; Luo L; Shen F; Huang Z
Toxicol Appl Pharmacol; 2021 Aug; 425():115606. PubMed ID: 34087332
[TBL] [Abstract][Full Text] [Related]
20. The mRNA and protein levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence, and risk of death in cervical cancer patients.
Bolaños-Suárez V; Alfaro A; Espinosa AM; Medina-Martínez I; Juárez E; Villegas-Sepúlveda N; Gudiño-Zayas M; Gutiérrez-Castro A; Román-Bassaure E; Salinas-Nieves ME; Bruno-Muñoz S; Aranda C; Flores-Herrera O; Berumen J
Cancer Med; 2023 Jul; 12(14):15632-15649. PubMed ID: 37326348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
